Navigation Links
Regional anesthesia reduces complications and death for hip fracture patients
Date:6/20/2012

PHILADELPHIA - In a study of more than 18,000 patients having surgery for hip fracture, researchers at the Perelman School of Medicine at the University of Pennsylvania found that the use of regional anesthesia versus general anesthesia, was associated with a significant reduction in major pulmonary complications and death. The new study will be published in the July issue of the journal Anesthesiology.

"Hip fracture is a common and costly event among older adults," said lead study author Mark D. Neuman, MD, assistant professor of Anesthesiology and Critical Care and senior fellow at the Leonard Davis Institute for Health Economics. "One out of five hip fracture patients dies within a year of their injury. There is an urgent need for better information to guide patients and clinicians make decisions about anesthesia for hip fracture surgery, but so far very few large observational studies in the general population have examined this issue."

Hip fractures are a global public health problem, occurring 1.6 million times worldwide, and their incidence is anticipated to grow rapidly during the next three decades because of the aging of the population. Most hip fractures occur in people older than 65, with the mortality and morbidity compilations increasing rapidly after age 80. A hip fracture almost always requires surgical repair or replacement, followed by weeks to months of physical therapy.

Dr. Neuman and his co-authors examined a retrospective cohort of patients undergoing surgery for hip fracture in 126 hospitals in New York in 2007 and 2008, which included a total of 18,158 patients. They tested the association of regional (epidural, spinal or nerve block) versus general anesthesia with inpatient mortality, major inpatient pulmonary complications, and major inpatient cardiovascular complications.

Among patients undergoing hip fracture surgery, the researchers found a 29 percent lower adjusted odds of mortality amon
'/>"/>

Contact: Jessica Mikulski
jessica.mikulski@uphs.upenn.edu
215-349-8369
University of Pennsylvania School of Medicine
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Patient Experience Regional Roundtables Announced by The Beryl Institute
2. Program to coordinate regional systems to speed heart attack care
3. Is it time for regional cardiovascular emergency care systems across the US?
4. Magnets may help prevent rare complication of spinal anesthesia
5. Recovery from propofol anesthesia may be sped by use of common stimulant
6. Long-term ICS use reduces pleural effusion in patients with CAP
7. Surgical removal of abdominal fat reduces skin cancer in mice
8. NIH study finds sigmoidoscopy reduces colorectal cancer rates
9. Automated breast ultrasound dramatically reduces physician interpretation time
10. Use of dedicated pediatric imaging departments for pediatric CT reduces radiation dose
11. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... WA (PRWEB) May 20, 2013 6Webs.com ... home alarm system reviews . 6Webs.com recently completed their ... the nation. Reviews are completed annually and the top ... factors which include their monitoring technology, equipment and warranties ... 6Webs.com stated, "When the 6Webs.com team completed the home ...
(Date:5/20/2013)... News) -- Dermatologists are saying that new federally ... make smarter choices when it comes to products ... new labels required by the U.S. Food and ... a sunscreen will protect against skin cancer in ... indicate whether a sunscreen is water-resistant, according to ...
(Date:5/20/2013)... Irving, Texas (PRWEB) May 20, 2013 ... and Phytel, the leader in automated, provider-led population ... health systems to effect change and successfully pursue ... of advisory services and technology to accelerate the ... of the VHA IMPERATIVTM performance improvement suite of ...
(Date:5/20/2013)... University in Sweden have mapped the significance of ... studies have previously examined whether different forms of ... coronary heart disease, ischemic stroke, peripheral arterial disease ... siblings and parents have suffered different types of ... is highest for atherosclerosis of the aorta followed ...
(Date:5/20/2013)... 20, 2013 Gilman Law LLP, a ... investigating Byetta lawsuits, is troubled by a new study ... and similar type 2 diabetes drugs are growing. ... Practices (ISMP), found that 71 Byetta pancreatic cancer reports ... Administration (FDA) as of June 30, 2012. ...
Breaking Medicine News(10 mins):Health News:Best Home Alarm System Companies in 2013 Published by Leading Security Reviews Site - 6Webs.com 2Health News:Revised Sunscreen Labels Should Help Consumers Make Wiser Choices 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 3Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 4Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 2Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 3
... , FRIDAY, Nov. 11 (HealthDay News) -- Vaccination ... type b (Hib) among young children in the United States ... That strain of flu was once the most common cause ... mid-1980s. But the researchers also found that other strains ...
... (November 11, 2011) Children treated at home for severe ... recover than children referred to health facilities, Save the Children ... Lancet medical journal today. The results come the ... world,s attention on the leading cause of child death. ...
... University of Michigan researchers will provide genetic testing and ... mild cognitive impairment. Researchers hope to ... caregivers respond to health education and genetic testing, says ... Behavior and Health Education at the U-M School of ...
... NOVEMBER 10, 2011 Results of the PARTNER ... replacement (TAVR) results in improved quality of life compared ... the transfemoral approach. The results of the study were ... (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation. ...
... between the ages of 18 and 25 report the highest ... Survey on Drug Use & Health. A new study from ... in prosocial behaviors, such as volunteering and helping others, are ... Carlo, Millsap Professor of Diversity in the Department of Human ...
... Foundation (AHAF), a nonprofit organization funding innovative research through ... the number of scientists seeking ADR research grants through ... "It,s a sign of difficult times for the ... Guy Eakin, Ph.D. "Finding government funding is tough ...
Cached Medicine News:Health News:Lancet pneumonia study offers new hope for reducing No. 1 cause of child death 2Health News:Lancet pneumonia study offers new hope for reducing No. 1 cause of child death 3Health News:Quality of life benefits of transcatheter aortic valve replacement differ by access site 2Health News:Volunteering, helping others decreases substance use in rural teens, MU study finds 2Health News:Requests for Alzheimer's disease research grants up by 33 percent, as federal funding in doubt 2Health News:Requests for Alzheimer's disease research grants up by 33 percent, as federal funding in doubt 3
(Date:5/17/2013)... , May 17, 2013 Medical devices are ... a biological product. In light of their different mechanisms, ... are much more complicated than drug trails due to ... MD safety instead of evaluating both safety and efficacy ... FDA (which is the same as the SFDA) evaluate ...
(Date:5/17/2013)... SAN DIEGO and CAMBRIDGE, Mass., May 17, 2013 ... announce that a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: ... District Court for the District of Massachusetts ... of its officers violated the Securities Exchange Act of ... May 1, 2013 (the "Class Period"). (Logo: ...
(Date:5/17/2013)...  TechAtlas Group has announced the release of ... for the Chronic Kidney Disease (CKD) market. This ... drugs and devices currently on the market and ... (Logo:  http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) ... renal denervation , diabetic nephropathy - antifibrotics ...
Breaking Medicine Technology:Statistical Challenges in Medical Device Trail Evaluation 2Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2
... Eli Lilly and Company,(NYSE: LLY ) ... with the,European Medicines Agency (EMEA) for centralised review ... for the,first-line treatment of advanced non-small cell lung ... more than 85 countries as a,second-line, single agent ...
... insulin glargine, exenatide offered added benefits of, ... with metformin --, AMSTERDAM, Netherlands, Sept. 21 ... Eli Lilly and Company (NYSE: LLY ),today ... insulin glargine on beta-cell function, glycemic control and ...
Cached Medicine Technology:Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 2Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 3Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 4Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 5Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 6Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 7Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 8Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 9Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 10Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 11Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 12One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 2One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 3One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 4One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 5One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 6One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 7
Stainless steel flexible ruler. graduated in 1/32 inches (.8 mm) fractions, as well as mm graduations....
Colorado Microneedles offer the surgeon precision in cutting and coagulation, without the expense and inconvenience of a laser. The needles may also be used for dissecting large areas such as the sca...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Medicine Products: